Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03081182|
Recruitment Status : Recruiting
First Posted : March 16, 2017
Last Update Posted : February 21, 2018
|Condition or disease||Intervention/treatment|
|Pancreatitis||Other: Data Management and Monitoring|
|Study Type :||Observational|
|Estimated Enrollment :||860 participants|
|Official Title:||Pediatric Longitudinal Cohort Study of Chronic Pancreatitis (INSPPIRE 2)|
|Actual Study Start Date :||March 16, 2017|
|Estimated Primary Completion Date :||March 2022|
|Estimated Study Completion Date :||March 2023|
|Pediatric Chronic Pancreatitis||
Other: Data Management and Monitoring
The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer Center responsible for monitoring protocol and regulatory compliance for all consortium studies.
CDMC responsible for maintaining and tracking IRB approval and regulatory documents from each site throughout the life of the study.
- Compliance Monitoring of Regulatory Documents for Consortium Study of Pediatric Chronic Pancreatitis [ Time Frame: 5 years ]The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer Center will monitor regulatory compliance at all participating institutions.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03081182
|Contact: Ziding Feng, PHD||713-563-4276||CR_Study_Registration@mdanderson.org|
|United States, Texas|
|University of Texas MD Anderson Cancer Center||Recruiting|
|Houston, Texas, United States, 77030|
|Contact: Clinical Research Operations CR_Study_Registration@mdanderson.org|
|Principal Investigator:||Ziding Feng, PHD||M.D. Anderson Cancer Center|